• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Archives for January 2019

US Congressional Watchdog Launches Team For Sci/Tech Analysis

31/01/2019 by Intellectual Property Watch Leave a Comment

A new chapter begins. The business of technology and science has been, and will increasingly be, the business of government: with this in mind, the US Government Accountability Office (GAO) has launched a new Science, Technology Assessment and Analytics (STTA) team with the aim to expand the support to lawmakers on topics whose importance has exponentially increased in the world of today.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Innovation/ R&D, New Technologies, North America, Patents/Designs/Trade Secrets, Regional Policy

WIPO Sheds Light On Artificial Intelligence Patenting Trends In New Report

31/01/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment

The World Intellectual Property Organization today released its first report on artificial intelligence showing a sharp rise in patenting activities over the last few years. WIPO Director General Francis Gurry called artificial intelligence a “game changer” during a press briefing yesterday and said WIPO hopes to spark a conversation on the issue among its member states this year. As in most other fields, leading patent offices are the United States and China.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Innovation/ R&D, New Technologies, Patents/Designs/Trade Secrets, WIPO

Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues

30/01/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment

Shortages, faulty supply chains, unbearable prices, weak health systems – the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing

30/01/2019 by David Branigan, Intellectual Property Watch Leave a Comment

A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspectives expressed, many formed consensus in calling for increased transparency of research and development (R&D) costs and equitable access to innovative cancer drugs.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO

WHO Holds Discussions On Roadmap For Improving Access To Medicines

29/01/2019 by Catherine Saez, Intellectual Property Watch 2 Comments

Unaffordable prices, unavailable medicines, a rising need for accessible noncommunicable diseases treatments – these set the stage as the World Health Organization Executive Board started discussion today on one of the more contentious issues of the week. For the Board’s approval is in particular a roadmap and action plan including a dual strategy based on safety and efficacy of health products, and their affordability.

Filed Under: IP Policies, Language, Themes, Venues, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO

DNDi, MMV Make 400 Compounds Available To Boost Pandemic Disease Research

29/01/2019 by Intellectual Property Watch Leave a Comment

The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) today announced the launch of the “Pandemic Response Box”, which offers researchers open access to 400 compounds that could lead to development of new treatments for pandemic diseases. In return, researchers “will be expected to share data resulting from research on the molecules from the box in the public domain within 2 years of its generation.” 

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Europe, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy

Measuring Outputs Seen As Key To WHO Transformation

29/01/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment

Measurable outputs are a key element of the World Health Organization transformation and its “triple billion” target. Last week, WHO Executive Board discussed the Impact Framework, a key measurement system. Board members asked clarifications on indicators and underlined the challenge of data collection in many countries. A consultation with country experts is expected to be held before the May World Health Assembly.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Copyright Policy, English, Finance, New Technologies, Technical Cooperation/ Technology Transfer, WHO

WHO Draft Resolution On Universal Health Coverage Shows Efforts At Consensus

28/01/2019 by Catherine Saez, Intellectual Property Watch 2 Comments

With half the world’s population still lacking access to essential health services, World Health Organization Executive Board members this week are working to agree on a resolution indicating ways through which this situation can be alleviated. Discussions are going on outside plenary room as delegates seek agreement on a draft resolution.

Filed Under: IP Policies, Language, Themes, Venues, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO, WTO/TRIPS

WHO’s Access Roadmap And The Art Of Accommodation Of Pharma Interest

26/01/2019 by Intellectual Property Watch 1 Comment

The Roadmap to access to medicines, vaccines and other health products (Roadmap) to be discussed at this week’s 144th session of WHO’s Executive Board accommodates vital interest of pharmaceutical TNCs on critical issues such as the approach to access, technical assistance on the use of TRIPS flexibilities and access to biosimilars.

Adoption of the Roadmap in its current form very well accommodates the interest of the Pharmaceutical TNCs and therefore one need not expect any proactive steps by WHO towards promoting access after the adoption of the Roadmap.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO, WIPO, WTO/TRIPS

Open Access Advocates See End Of US Copyright Term Extension Act As Win For Commons

25/01/2019 by David Branigan, Intellectual Property Watch 1 Comment

Open access advocates in the United States are celebrating the expiration, and non-renewal, of the Copyright Term Extension Act, which introduces into the public domain all works from 1923, and signals an end of the practice by US lawmakers to continually extend the terms of copyright protection.

Leading figures from groups such as Creative Commons and Wikimedia Foundation gathered to discuss why this shift in policy took place, and what it means for the public domain. They asserted that this change is the result of a general acceptance of the value of “the commons,” brought on in part by the era of the internet.

Filed Under: IP Policies, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Information and Communications Technology/ Broadcasting, Lobbying, North America, Regional Policy

  • 1
  • 2
  • 3
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2021 · Global Policy Reporting